Hengcheng Pharmaceutical Group Huainan Co., Ltd. is located in the Bio-Pharmaceutical Technology Park of Huainan Economic and Technological Development Zone in Anhui Province. It is a comprehensive pharmaceutical and chemical enterprise primarily engaged in the production of synthetic active pharmaceutical ingredients (APIs), alongside tablets, capsules, and niclosamide-series pesticide products. The company was formerly known as Anhui Dongsheng Pharmaceutical Co., Ltd.

As a high-tech enterprise, the company currently employs over 130 staff members. Upholding the corporate spirit of "Perseverance, Integrity, Self-Reliance, and Innovation," the company relies on high-tech products, implements an outward-oriented development strategy, and vigorously explores both international and domestic markets, achieving sound economic and social benefits. In 2022, the company realized sales revenue of over 82 million RMB and generated approximately 2 million USD in export earnings. Due to its effective management and outstanding operational performance, Hengcheng Pharmaceutical Huainan Co., Ltd. has been consistently recognized by the Huainan Municipal Government with honors such as "Huainan Advanced Enterprise in Import and Export," "Huainan Advanced Unit for Work Safety and Health (Ankang Cup)," and "Huainan Advanced Unit for Work Safety." In 2010, it was also rated as an "AA-Level Tax Credit Enterprise" in Anhui Province.

The company's main products include: API intermediates such as niclosamide series products and niclosamide piperazine salt; solid dosage forms including Mesalazine Enteric-Coated Tablets (Anjiesha), Nimesulide Capsules, anti-tuberculosis drugs like Rifampicin Capsules, Ethambutol Hydrochloride Tablets, Isoniazid Tablets, and Pyrazinamide Tablets; pesticide formulations such as 50% Niclosamide Ethanolamine Salt Wettable Powder and 70% Niclosamide Wettable Powder. Among these, niclosamide is one of the company's key export-oriented API products. The product incorporates advanced production technology from Germany's Bayer AG, enhanced through technological innovation to form a unique production process. It features mature technology and stable product quality. It is also a collaborative product with Bayer AG, which acts as the global sales agent. The product is mainly exported to over thirty countries and regions across Europe, America, Asia, and Africa, generating annual export earnings of about 2 million USD. As a molluscicide, the niclosamide series products have consistently won bids in domestic procurement tenders for schistosomiasis prevention and control medicines for many years.

Hengcheng Pharmaceutical Group Huainan Co., Ltd. adheres to the management philosophy of "People-Oriented, Quality-First," and upholds the development concepts of high-quality growth and innovation-driven progress. It strives to expand and strengthen the enterprise while making positive contributions to social development.

We warmly welcome talented individuals to join Hengcheng Pharmaceutical and work together to accelerate the company's growth!